- Home
- MDLZ vs EW Comparison
MDLZ vs EW Comparison
Compare MDLZ & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDLZ | EW |
|---|---|---|
| Founded | 2000 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.5B | 49.5B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | MDLZ | EW |
|---|---|---|
| Price | $57.63 | $84.42 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 21 |
| Target Price | $66.89 | ★ $96.79 |
| AVG Volume (30 Days) | ★ 10.1M | 3.1M |
| Earning Date | 02-03-2026 | 02-10-2026 |
| Dividend Yield | ★ 3.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.69 | 2.33 |
| Revenue | ★ $37,645,000,000.00 | $5,883,800,000.00 |
| Revenue This Year | $7.29 | $14.35 |
| Revenue Next Year | $3.82 | $9.73 |
| P/E Ratio | ★ $21.30 | $36.54 |
| Revenue Growth | 4.13 | ★ 10.60 |
| 52 Week Low | $51.20 | $65.94 |
| 52 Week High | $71.15 | $87.89 |
Technical Indicators
Market Signals| Indicator | MDLZ | EW |
|---|---|---|
| Relative Strength Index (RSI) | 61.96 | 49.04 |
| Support Level | $56.68 | $82.82 |
| Resistance Level | $58.33 | $84.55 |
| Average True Range (ATR) | 1.30 | 1.90 |
| MACD | 0.47 | -0.09 |
| Stochastic Oscillator | 90.11 | 58.05 |
Price Performance
Historical ComparisonAbout MDLZ Mondelez International Inc.
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (49% of sales as of the end of fiscal 2024), chocolate (31%), gum/candy (11%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one-third of its revenue from developing markets, more than one-third from Europe, and the remainder from North America.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.